Ridinilazole: a novel antimicrobial for Clostridium difficile infection

por Cho, Jonathan C., Crotty, Matthew P., Pardo, Joe
Publicado 2019

2903. Early Experience With Omadacycline For The Treatment Of Diabetic Foot Infections

por Crotty, Matthew P, Akins, Ronda L, Dominguez, Edward A, Alexander, Julie, Alexander, Nebu
Publicado 2023

2244. What Happened? Antibiotic Resistance During the First Two Years of the SARS-CoV-2 (COVID-19) Pandemic

por Crotty, Matthew P, Henderson, Joel, Hohulin, Jacqueline, Wright, Jennifer, Cui, Mingyang, Alexander, Julie, Hunter, Leigh, Hupert, Mark, Dominguez, Edward A
Publicado 2023

Susceptibility of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Against a Collection of β-Lactam-Resistant Gram-Negative Bacteria

por Gonzalez, Mark D., McMullen, Allison R., Wallace, Meghan A., Crotty, Matthew P., Ritchie, David J., Burnham, Carey-Ann D.
Publicado 2017

Learning Experiences Within Infectious Diseases Pharmacy Residency Programs in the United States: A Cross-Sectional Survey

por Cho, Jonathan C, Crotty, Matthew P, Kufel, Wesley D, Chahine, Elias B, Sofjan, Amelia K, Gallagher, Jason C, Estrada, Sandy J
Publicado 2019

Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship

por Crotty, Matthew P., Meyers, Shelby, Hampton, Nicholas, Bledsoe, Stephanie, Ritchie, David J., Buller, Richard S., Storch, Gregory A., Kollef, Marin H., Micek, Scott T.
Publicado 2015

Epidemiology, Co-Infections, and Outcomes of Viral Pneumonia in Adults: An Observational Cohort Study

por Crotty, Matthew P., Meyers, Shelby, Hampton, Nicholas, Bledsoe, Stephanie, Ritchie, David J., Buller, Richard S., Storch, Gregory A., Micek, Scott T., Kollef, Marin H.
Publicado 2015